The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
A Marx, F Pfister, B Schalke, G Saruhan-Direskeneli… - Autoimmunity …, 2013 - Elsevier
The thymus plays distinct roles in the pathogenesis of the different Myasthenia gravis (MG)
subtypes. Inflammatory, neoplastic and age-related alterations of the thymus are of pivotal …
subtypes. Inflammatory, neoplastic and age-related alterations of the thymus are of pivotal …
Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
E Gianchecchi, DV Delfino, A Fierabracci - Autoimmunity reviews, 2013 - Elsevier
Autoimmune diseases represent a heterogeneous group of conditions whose incidence is
increasing worldwide. This has stimulated studies on their etiopathogenesis, derived from a …
increasing worldwide. This has stimulated studies on their etiopathogenesis, derived from a …
The role of PTPN22 in the pathogenesis of autoimmune diseases: A comprehensive review
The incidence of autoimmune diseases is increasing worldwide, thus stimulating studies on
their etiopathogenesis, derived from a complex interaction between genetic and …
their etiopathogenesis, derived from a complex interaction between genetic and …
NK cells in autoimmune diseases: Linking innate and adaptive immune responses
E Gianchecchi, DV Delfino, A Fierabracci - Autoimmunity Reviews, 2018 - Elsevier
The pathogenesis of autoimmunity remains to be fully elucidated, although the contribution
of genetic and environmental factors is generally recognized. Despite autoimmune …
of genetic and environmental factors is generally recognized. Despite autoimmune …
Role of type 1 diabetes–associated SNPs on risk of autoantibody positivity in the TEDDY study
C Törn, D Hadley, HS Lee, W Hagopian, Å Lernmark… - Diabetes, 2015 - Am Diabetes Assoc
The Environmental Determinants of Diabetes in the Young (TEDDY) study prospectively
follows 8,677 children enrolled from birth who carry HLA-susceptibility genotypes for …
follows 8,677 children enrolled from birth who carry HLA-susceptibility genotypes for …
Dendritic cells and their immunotherapeutic potential for treating type 1 diabetes
FU Khan, P Khongorzul, AA Raki… - International journal of …, 2022 - mdpi.com
Type 1 diabetes (T1D) results from the destruction of pancreatic beta cells through a process
that is primarily mediated by T cells. Emerging evidence suggests that dendritic cells (DCs) …
that is primarily mediated by T cells. Emerging evidence suggests that dendritic cells (DCs) …
Recent advances on microbiota involvement in the pathogenesis of autoimmunity
E Gianchecchi, A Fierabracci - International journal of molecular sciences, 2019 - mdpi.com
Autoimmune disorders derive from genetic, stochastic, and environmental factors that all
together interact in genetically predisposed individuals. The impact of an imbalanced gut …
together interact in genetically predisposed individuals. The impact of an imbalanced gut …
Molecular mechanisms in autoimmune type 1 diabetes: a critical review
Z **e, C Chang, Z Zhou - Clinical reviews in allergy & immunology, 2014 - Springer
Autoimmune type 1 diabetes is characterized by selective destruction of insulin-secreting
beta cells in the pancreas of genetically susceptible individuals. The mechanisms …
beta cells in the pancreas of genetically susceptible individuals. The mechanisms …
Thymoma related myasthenia gravis in humans and potential animal models
A Marx, S Porubsky, D Belharazem… - Experimental …, 2015 - Elsevier
Thymoma-associated Myasthenia gravis (TAMG) is one of the anti-acetylcholine receptor
MG (AChR-MG) subtypes. The clinico-pathological features of TAMG and its pathogenesis …
MG (AChR-MG) subtypes. The clinico-pathological features of TAMG and its pathogenesis …
Etiology of myasthenia gravis: innate immunity signature in pathological thymus
P Cavalcante, P Cufi, R Mantegazza, S Berrih-Aknin… - Autoimmunity …, 2013 - Elsevier
Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction
(NMJ), whose clinical hallmark is muscle weakness and early fatigability. The main target of …
(NMJ), whose clinical hallmark is muscle weakness and early fatigability. The main target of …